EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome

Yu Gao iD, Wujuan Li, Xiaoyu Huang, Yuhong Lyu, Changwu Yue iD

Microorganisms · 24.04.2024 · 12 (5) · 851

DOI: 10.3390/microorganisms12050851 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 24.04.2024. Verfasst von Yu Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yan'an Key Laboratory of Microbial Drug Innovation and Transformation, School of Basic Medicine, Yan'an University, Yan'an 716000, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yan 'an University transformation of Scientific and Technological achievements, Yan’an University Qin Chuanyuan “Scientist + Engineer” team Special, Yan’an University transformation of Scientific and Technological achievements.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous investigations have illuminated the significant association between the gut microbiome and a broad spectrum of health conditions, including obesity, diabetes, cardiovascular diseases, and psychiatric disorders. Evidence from certain studies suggests that dysbiosis of the gut microbiota may play a role in the etiology of obesity and diabetes. Moreover, it is acknowledged that dietary habits, pharmacological interventions, psychological stress, and other exogenous factors can substantially influence the gut microbial composition. For instance, a diet rich in fiber has been demonstrated to increase the population of beneficial bacteria, whereas the consumption of antibiotics can reduce these advantageous microbial communities. In light of the established correlation between the gut microbiome and various pathologies, strategically altering the gut microbial profile represents an emerging therapeutic approach. This can be accomplished through the administration of probiotics or prebiotics, which aim to refine the gut microbiota and, consequently, mitigate the manifestations of associated diseases. The present manuscript evaluates the recent literature on the relationship between gut microbiota and metabolic syndrome published over the past three years and anticipates future directions in this evolving field.

Schlagwörter

Stichwörter der Autor:innen

dysbiosisgut microbiomemetabolic syndromeprebioticsprobiotics

Autor:innen und Institutionen

  • Yan'an Key Laboratory of Microbial Drug Innovation and Transformation, School of Basic Medicine, Yan'an University, Yan'an 716000, China.
  • Shaanxi Engineering and Technological Research Center for Conversation and Utilization of Regional Biological Resources, Yan'an University, Yan'an 716000, China.

ORCID-Profile: Yu Gao, Changwu Yue

Förderung

  • Yan 'an University transformation of Scientific and Technological achievements
  • Yan’an University Qin Chuanyuan “Scientist + Engineer” team Special
  • Yan’an University transformation of Scientific and Technological achievements
  • National College Students Innovation and Entrepreneurship Training Program
  • Yan’an Science and Technology Bureau Key Science and Technology Research and Development Program
  • Yan’an University’s production cultivation project
  • Shaanxi Provincial Natural Science Basic Research Program

Zitieren

APA

Gao, Y., Li, W., Huang, X., Lyu, Y., & Yue, C. (2024). Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome. Microorganisms, 12(5), 851. https://doi.org/10.3390/microorganisms12050851

Vancouver

Gao Y, Li W, Huang X, Lyu Y, Yue C. Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome. Microorganisms. 2024;12(5):851. doi:10.3390/microorganisms12050851

BibTeX
@article{Gao2024,
  author = {Gao, Yu and Li, Wujuan and Huang, Xiaoyu and Lyu, Yuhong and Yue, Changwu},
  title = {Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {5},
  pages = {851},
  doi = {10.3390/microorganisms12050851}
}
Kostenlos starten →